ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 1 filers reported holding ANAPTYSBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,510 | -11.8% | 307 | 0.0% | 0.00% | – |
Q2 2023 | $6,244 | -6.5% | 307 | 0.0% | 0.00% | – |
Q1 2023 | $6,677 | -29.8% | 307 | 0.0% | 0.00% | – |
Q4 2022 | $9,510 | +18.9% | 307 | 0.0% | 0.00% | – |
Q3 2022 | $8,000 | +33.3% | 307 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | -25.0% | 307 | 0.0% | 0.00% | – |
Q1 2022 | $8,000 | -27.3% | 307 | 0.0% | 0.00% | – |
Q4 2021 | $11,000 | -91.9% | 307 | -95.1% | 0.00% | -100.0% |
Q1 2021 | $136,000 | +0.7% | 6,300 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $135,000 | +45.2% | 6,300 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $93,000 | -34.0% | 6,300 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $141,000 | +58.4% | 6,300 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $89,000 | -50.0% | 6,300 | +23.9% | 0.00% | -40.0% |
Q3 2019 | $178,000 | -16.4% | 5,085 | +35.0% | 0.01% | -16.7% |
Q2 2019 | $213,000 | – | 3,768 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |